As of 2026-03-25, the Fair Value of Allogene Therapeutics Inc (ALLO) is -4.25 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 2.21 USD, the upside of Allogene Therapeutics Inc is -292.17%.
With the market price of 2.21 USD and our fair value calculation, Allogene Therapeutics Inc (ALLO) is not a good investment. Investing in ALLO stocks now will result in a potential loss of 292.17%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | 5Y Avg | |
| Net income | -257.01 | -332.63 | -327.26 | -257.59 | -190.89 | -273.08 |
| YoY growth | -2.71% | -29.42% | 1.61% | 21.29% | 25.90% | 3.33% |
| Market Cap (mil) | 496.65 |
| P/E | |
| Forward P/E |
| EPS | -0.85 |
| Avg earnings growth rate | 3.33% |
| TTM earnings | -190.89 |